Ensuring Accuracy and Reliability in Testing the Quality of Pharmaceutical Compounds: A Review on Qualification of Analytical Instruments with their Applications

Rajitha Galla¹, Susmitha Aggarapu^1,2*, Gireesh Kumar Eri², Geetha Susmita Adepu²,

Mounika Jampani², Padma Sree Yellamraju², Swarnalatha Dugasani²

¹Institute of Pharmaceutical Technology,

Sri Padmavati Mahila Visvavidyalayam, Tirupati - 517502, Andhra Pradesh, India.

²Annamacharya College of Pharmacy, Rajampet - 516126 Andhra Pradesh, India.

*Corresponding Author E-mail: aggarapusuma@gmail.com

ABSTRACT:

Analytical instruments are used to perform quality control tests and measurements in pharmaceutical laboratories, impacting decisions related to quality of products and their approval by regulatory authorities such as Food and drug administration (FDA). Therefore, their qualification is of paramount importance in maintaining product quality, patient safety, and regulatory compliance. It helps in ensuring that pharmaceutical products are safe, effective, and free from defects, ultimately protecting the health and well-being of patients. Also, it ensures that the qualified instruments foster continuous improvement in their performance which contribute to accurate testing of drug substances and their products, quality assurance and preventing the release of substandard products into the market. This critical review delves into the multifaceted process of qualifying analytical instruments, emphasizing the significance of accuracy, reliability, and adherence to established guidelines. The article explores regulatory requirement and qualification stages of instruments/equipment such as design qualification, installation qualification, operational qualification, performance qualification for the majorly used  instruments like electronic balance, pH meter, UV-visible spectrophotometer, fourier transform infra-red spectrophotometer (FTIR), high performance liquid chromatograph (HPLC), gas chromatograph (GC) and high performance thin layer chromatograph (HPTLC). By comprehensively evaluating these aspects, this review highlights the pivotal role of qualification of instruments in sustaining the integrity of testing pharmaceutical samples.

KEYWORDS: Design qualification, Installation qualification, Operational qualification, Performance qualification, Analytical instruments.

INTRODUCTION:

Analytical instruments are indispensable in the pharmaceutical and chemical industries, forming the backbone of quality assurance processes. These instruments are utilized in various stages of drug and chemical product development, including raw material testing, in-process quality checks, and final product analysis. Their role extends beyond routine testing to support regulatory filings, stability studies, and research and development, ensuring that products consistently meet stringent quality and safety standards.¹ The pharmaceutical industry operates under stringent regulations, necessitating adherence to strict quality standards to protect public health.^2-4

Regular testing and analysis are performed throughout the drug development and production stages^5-7, with any equipment or instrument failure potentially leading to compromised product quality and potential harm to patients. Therefore, qualification of these instruments is both a regulatory and quality imperative. Qualification ensures that an instrument consistently performs within specified parameters, confirming its functionality, accuracy, and reliability throughout its operational life⁸. Regulatory bodies like the FDA^9,10 and EMA¹¹ have established guidelines for instrument qualification to ensure consistency and reliability. Non-compliance with these guidelines can result in severe consequences, including regulatory actions, product recalls, and reputational damage. Consequently, the primary goal of pharmaceutical industries is to produce safe and effective medicines, thereby enhancing patient outcomes. As the industry advances, the qualification process must evolve to address new challenges and opportunities. Existing literature^12-16 has generally described qualification stages and calibration procedures for only a few instruments. However, a comprehensive review of the qualification processes for individual analytical instruments is lacking. This review aims to fill that gap by outlining the different qualification stages for the most widely used instruments in the pharmaceutical industry.

Classification of Instruments:

Instruments in modern laboratories vary widely, requiring different qualification approaches. Classification into Class I, II, and III (Fig. 1) helps to determine the level of qualification needed^17,18.

Fig. 1. Classification of instruments

Class II and Class III instruments require calibration and qualification because they provide measured values or control important physical parameters essential for accurate and reliable laboratory testing, whereas Class I instruments, lacking measurement capabilities and performing basic functions, do not require such rigorous calibration and qualification. Regular calibration is a cornerstone of quality control in laboratories, ensuring that instruments continue to provide accurate measurements that align with true values and perform consistently over time. This is crucial during the development phase of new drugs to ensure that the active ingredients are present in the correct amounts and that the drug will perform as expected in clinical trials and eventual consumer use. In drug testing, precise and reliable measurements are vital to ensure that drugs are safe and effective for patient use^19,20.

Calibration helps in achieving this by ensuring that the instruments used for measuring drug concentrations, impurities, and other critical parameters are accurate and reliable²¹. The calibration frequencies for each instrument are detailed in Table 1.

Table 1: Calibration frequency of instruments along with significance

Instrument	Interval/periodicity	Significance
Electronic balance	Daily	Precision Accuracy Reliability Consistency Sensitivity Reproducibility Stability
pH meter	Daily
UV-Visible spectrophotometer	Monthly once ±3days
HPLC	3±7 days
GC	3±7 days
HPTLC	3±7 days
FTIR	Monthly once ±3days

Qualification:^22-31

The qualification is a multi-stage process that involves verifying and documenting the design, proper installation, operational functionality, and performance capabilities of equipment/instruments. Each stage serves a distinct purpose in ensuring that they operate accurately, reliably, and consistently within specified parameters. Usually, it starts with customer requirements or user requirement specifications (URS) and ends with performance qualification.

Customer Requirements or User Requirement Specifications:

Customers or users of the equipment have specific expectations, often articulated in layman's terms, regarding various parameters such as size, speed, effectiveness, availability of spare parts, ease of operation and maintenance, low dust and sound generation, reliability, materials of construction, auto control systems, ease of changeover, and overall construction quality. These requirements are discussed with equipment manufacturers, influencing the selection of equipment. The manufacturer then prepares a design qualification report for user approval, especially for custom items, while standard items typically adhere to the manufacturer's specifications.

Design Qualification (DQ):

DQ is the documented evidence that the design of the equipment/instrument meets user specifications and GMP requirements. It ensures the instrument's design is suitable for its intended use, aligns with regulatory standards and industry best practices, and addresses user requirements. It involves evaluating the design against functional specifications, identifying and addressing risks, and ensuring compliance with regulatory guidelines. The DQ process should be conducted prior to the purchase of a new model of instrument and includes activities such as assuring the manufacturer's DQ, confirming the availability of adequate support from the manufacturer, and verifying the instrument's fitness for use in the laboratory.

Installation Qualification (IQ)l:

IQ confirms that the instrument is correctly installed according to design specifications and manufacturer recommendations. It involves verifying the presence and proper installation of all components, checking electrical connections, utilities, and environmental requirements, reviewing documentation, and ensuring adherence to regulatory and safety requirements. This stage establishes a foundation for accurate equipment operation. It should be conducted at the installation of each instrument (new, old, or existing unqualified) and includes activities such as description, instrument delivery, utilities/facility setup, assembly and installation, network and data storage, and installation verification.

Operational Qualification (OQ):

OQ assesses the instrument operational functionality under various conditions to confirm it operates as intended. This involves testing the equipment's ability to perform its functions within specified parameters, verifying control systems and safety features, and testing under a range of operational conditions. OQ ensures the instrument functions as expected and meets performance criteria. It should be conducted after installation or major repair of each instrument and includes activities such as fixed parameters, environment checks, secure data storage, backup and archive, and instrument function tests.

Performance Qualification (PQ):

PQ is the final stage, evaluating the equipment's performance using actual samples or products in a real-world operating environment. It involves running the equipment with actual materials, conducting tests under normal production conditions, and analyzing the results to verify they meet acceptance criteria. It validates the equipment's capability to consistently produce accurate and reliable results, ensuring it maintains performance over time and across various conditions. This should be conducted periodically at specified intervals for each instrument and includes activities such as preventive maintenance and repairs, establishing practices to address operation, calibration, maintenance, and change control, and performance checks.

Comprehensive Qualification Protocol:

These four stages DQ, IQ, OQ, and PQ are integrated into a comprehensive qualification protocol, with each stage depending upon the previous one. This logical progression of testing and verification ensures that the equipment/instrument is suitable for its intended use and meets regulatory requirements and industry standards.

Qualification of Analytical Instruments:

Electronic Balance:

The qualification of an electronic balance is, essential to ensure accurate and reliable mass measurements, critical for maintaining quality and compliance in research and manufacturing laboratories³². In qualification of electronic balance, DQ stage ensures the design of the balance meets requirements and specifications before purchase, focusing on accuracy, precision, and compliance with standards. IQ confirms correct setup and integration according to manufacturer and site-specific guidelines, ensuring all components are present and operational. OQ tests the balance's performance under various conditions, including accuracy, linearity, precision, eccentricity, linearity error, and drift (Table 2). PQ demonstrates consistent performance under actual working conditions, using repeatability, corner load, accuracy, and linearity tests with representative samples.

Table 2: Qualification tests of electronic balance and pH meter

Instrument	Test	Significance
Electronic Balance	Accuracy: Measure mass of certified weights (5%, 50%, 100% capacity) five times each. Weighing difference NMT 0.001.	Ensures the balance provides correct weight measurements, crucial for precise data in research and manufacturing.
	Linearity: Calculate correlation coefficient from accuracy measurements. k = 1±0.0001.	Confirms that the balance provides accurate readings at different weights, ensuring consistent performance throughout its entire capacity.
	Precision: Weigh a 50% capacity weight five times. %RSD NMT 2%.	Validates the balance’s reliability and repeatability, which is essential for obtaining consistent and reproducible results.
	Eccentricity: Weigh 30% capacity weight at multiple positions on the pan. %RSD NMT 0.05%.	Ensures the balance can provide accurate measurements regardless of where the sample is placed, indicating robustness and reliability.
	Linearity Error: Test with four weights and calculate error. Linearity error ≤ balance accuracy.	Assesses the balance’s accuracy in summing weights, which is important for complex weighing operations involving multiple components.
	Drift Test: Measure a control weight every 5 minutes for 30 minutes, in the morning and afternoon. %RSD = 0.05%.	Ensures the balance maintains its accuracy over prolonged use, which is vital for long-term experiments and processes.
pH Meter	Verify electrode sensitivity by stabilizing readings in pH 4.01, 7.0 and 9.21 buffer solutions, adjusting calibration if necessary.	Assesses capability to handle variable samples while maintaining accuracy.

pH Meter:

The qualification of a pH meter is crucial for ensuring accurate and reliable measurements of hydrogen ion activity, which is essential for testing the pH of various kinds of samples³³. In its qualification process, DQ evaluates the pH meter's design and specifications to ensure they meet the intended requirements, including accuracy, precision, measurement range, and resolution. It confirms the device suitability for the intended application and compliance with industry regulations. IQ ensures proper installation, calibration, and integration of the pH meter, verifying the setup according to the manufacturer's recommendations and site-specific requirements, and documenting the process to ensure readiness for testing. OQ verifies the instrument accuracy and consistency within specified parameters through a series of tests (Table 2), including calibration with standard buffer solutions and stability tests. PQ demonstrates the device ability to provide accurate and reliable measurements under real-world conditions, involving measurements with standard buffer solutions and known samples, performance assessment over time, and evaluation of accuracy and precision with challenging samples. This comprehensive qualification process ensures the pH meter meets desired specifications and regulatory standards.

UV Visible Spectrophotometer:

The qualification of a double beam UV-Visible spectrophotometer is essential to ensure accurate and reliable performance in analytical and clinical laboratories³⁴ in the analysis of pharmaceutical dosage forms^35-37. In qualification of this spectrophotometer³⁸, DQ involves evaluating the instrument’s design and specifications to confirm they meet the required standards, including wavelength range, resolution, accuracy, and linearity, while also ensuring compliance with industry regulations and quality control standards. IQ verifies that the instrument is properly installed according to the manufacturer's guidelines and site-specific conditions, ensuring all components and utilities are correctly set up. OQ assesses the instrument’s functionality through various tests, such as wavelength accuracy, control of absorbance, stray light limits, and resolution power, ensuring the instrument operates within its specified parameters (Table 3). PQ demonstrates that the instrument consistently performs accurately under routine and varying operating conditions, involving tests for wavelength accuracy, baseline stability, resolution, signal-to-noise ratio, stray light, reproducibility, and sensitivity. This comprehensive qualification process ensures the UV-Visible spectrophotometer meets the necessary specifications for precise and dependable use.

Fourier Transform Infra-Red Spectrometer (FTIR):

It is a reliable technique for identifying and quantifying organic and inorganic compounds such as paints, adhesives, resins, polymers, coatings, and drugs. It is also used for mapping cellular components like carbohydrates, lipids, and proteins to identify abnormal cells. Qualification of FTIR systems³⁹ ensures that they meet regulatory requirements and provide accurate, reliable results of types of functional groups in the given compound. During the qualification of FTIR, DQ involves evaluating the design and specifications to ensure they align with requirements, including spectral range, resolution, and accuracy. IQ ensures proper installation and integration of all components such as sample cells, detectors, and software. OQ verifies the system’s operational accuracy and consistency through specific tests like wavelength accuracy, resolution, and spectral reproducibility (Table 3). PQ demonstrates the system’s ability to consistently provide accurate and reliable results under practical conditions. This includes analyzing standard samples, evaluating long-term performance, and ensuring the system meets required specifications.

Table 3: Qualification Tests of UV- Visible and FTIR Spectrophotometers

Instrument	Test	Significance
UV-Visible spectrophotometer	Wavelength Accuracy: Verify wavelength accuracy using known absorption peaks (e.g., holmium perchlorate, hydrogen lamp lines).	Ensures instrument meets specified tolerances for wavelength accuracy and absorbance precision.
	Control of absorbance: Measure absorbance of K2Cr2O7 solution at designated wavelengths.	Ensures instrument meets specified tolerances for wavelength accuracy and absorbance precision.
	Limit of stray light: Measure absorbance of KCl solution.	Assesses stray light levels and ensure minimal interference.
	Resolution power: Evaluate spectral resolution using toluene in hexane.	Assesses instrument sensitivity and differentiation capability.
	Baseline Stability: Monitor baseline absorbance over time.	Ensures stable instrument performance.
	Signal to Noise Ratio (Noise Level): Measure noise level from absorbance of blank solutions	Ensures low noise interference.
	Sensitivity: Measure absorbance of low-concentration solutions	Determines instrument sensitivity as per application requirements.
	Reproducibility: Evaluate %RSD from multiple absorbance measurements	Ensures consistent results.
FTIR Spectrophotometer	Wavenumber Accuracy: Calibrate using characteristic wavenumbers of a polystyrene film.	Ensures that the wavenumber scale of the FTIR spectrometer is calibrated correctly.
	Wavenumber Precision: Measure substances with well-known peak positions (e.g., carbon dioxide, water vapor) and check the precision of the wavenumber readings.	Ensures that the instrument can consistently reproduce the same wavenumber readings for a given sample.
	0% Transmittance: Measure a sample that does not allow light transmission (should be 0% T).	Validates that the instrument can accurately measure zero light transmission
	100% Transmittance: Perform analysis without a sample (should be 100% T).	Confirms the instrument's ability to measure full light transmission
	Linearity Curve: Create calibration curve for %transmittance and concentration (r^2 > 0.99).	Evaluates the instrument's ability to produce a linear response over a range of concentrations.
	Reproducibility: Measure a stable sample twice within a short period (%RSD < 2%).	Ensures that the instrument can produce consistent results over repeated measurements
	Power Spectrum: Estimate the intensity of power spectrum at specified wavenumbers (measured intensity ≥ criterion value).	Assesses the instrument's power spectrum, ensuring that it can detect signals at specified wavenumbers with sufficient intensity.
	Resolution: Record spectrum of a polystyrene film and check for the depth of the troughs in the specified regions.	Determines the instrument's ability to distinguish between closely spaced absorption peaks.

High-Performance Liquid Chromatograph (HPLC):

The qualification of a HPLC system is crucial to ensure its robust performance in the separation, identification, and quantitation of various samples^40,41. In 1980, HPLC method came first time for the assay of bulk drug substances^42,43 and later it was extended for the determination in biological matrix⁴⁴. it has become the principal method in USP XXVII⁴⁵ and to a lesser extent but one of the most widely used methods also in European pharmacopoeia⁴⁶. DQ involves assessing the HPLC system's design and specifications, such as flow rates, column capacity, detection wavelength range, and resolution, to ensure they meet the intended requirements and regulatory standards. IQ ensures the equipment is properly installed according to the manufacturer’s guidelines and site-specific conditions, verifying components, connections, and initial performance against reference chromatograms. OQ establishes that the instrument operates within specified tolerances through various tests (Table 4), including flow rate accuracy, injector accuracy, system precision, wavelength accuracy, detector and injector linearity, column oven temperature accuracy, and gradient performance. PQ confirms consistent performance using standard analytes and real samples, ensuring system accuracy, precision, and reliability over extended periods and varying conditions. Documenting the results of these qualification stages ensures compliance with cGMP and regulatory requirements, validating the HPLC system’s readiness for routine analytical tasks.

Gas Chromatograph (GC):

The qualification⁴⁷ of a GC system is essential to ensure its performance in separating and quantifying drugs, residual solvents, volatile samples, process related impurities in pharmaceutical products etc. DQ evaluates the GC system's design and specifications, including column types, detectors, temperature control, and data handling capabilities, ensuring compliance with regulatory guidelines and suitability for intended applications. IQ ensures the system is correctly installed, calibrated, and integrated into its designated environment, with all components properly assembled and connected according to the manufacturer’s recommendations. OQ verifies the instrument's operation within specified tolerances through various tests (Table 4), such as flow rate accuracy, column oven temperature accuracy, system precision, detector linearity, and detector noise and drift, ensuring reliable performance. PQ demonstrates the GC system's ability to provide accurate and reliable results in practical conditions, assessing accuracy, precision, and detection limits over an extended period and varying conditions. Documenting the results of these qualification stages ensures compliance with cGMP and regulatory requirements, validating the GC system’s readiness for routine analytical tasks.

High-Performance Thin Layer Chromatograph (HPTLC):

HPTLC is a sophisticated technique offering superior separation efficiency and validated methods for qualitative and quantitative analysis of synthetic samples^48-50 and herbal based samples⁵¹. It is crucial to qualify HPTLC systems to ensure they meet regulatory requirements and provide accurate, reliable results. In its qualification process, DQ involves reviewing the system's design and specifications to ensure they meet intended requirements. IQ ensures proper installation and integration of all components. OQ verifies the system's operational accuracy and consistency through specific tests such as linearity and reproducibility of spotting, detector capacity (Table 4). PQ demonstrates the system's ability to consistently deliver accurate and reliable results under practical conditions. Thorough qualification of HPTLC systems supports compliance and enhances analytical reliability.

Table 4: Qualification tests of HPLC, GC and HPTLC

Instrument	Test	Significance
HPLC	Flow Rate Accuracy: Verify flow rate measurement accuracy (within ± 2.0%).	Confirms flow rate stability at various settings
	Injector Accuracy: Measure and confirm injection volume accuracy (50.0±1.0 µl).	Ensures consistent and precise sample injection volumes.
	System Precision: Calculate %RSD of retention times and peak areas for six replicates (NMT 2%).	Verifies repeatability of retention times and peak areas
	Wavelength Accuracy: Ensure absorbance is within ±2 nm of specified value.	Monitor baseline noise, drift, and lamp intensity for UV detectors.
	Detector Linearity: Assess linearity of detector response with varying sample concentrations (r^2 ≥ 0.99).	Confirms linear response.
	Injector Linearity: Validate injection volume linearity (r^2 ≥ 0.99).	Ensures minimal carry-over by the autosampler.
	Column Oven Temperature Accuracy: Measure accuracy at 30°C and 60°C (within ±2°C).	Verifies temperature settings within ±2°C.
	Gradient Performance: Verify gradient program accuracy (height composition within ±1.0%).	Check solvent composition accuracy and precision for gradient pumps.
GC	Flow Rate Accuracy: Measure flow rate accuracy for carrier gases (±10% of set flow).	Verify flow rates for various carrier gases.
	Column Oven Temperature Accuracy: Measure temperature at set points.	Validate temperature accuracy at multiple settings (±2°C).
	System Precision: Check %RSD for retention times and peak areas.	Assess %RSD for retention times (NMT 1%) and peak areas (NMT 5%).
	System Precision for Headspace Autosampler: Assess %RSD for retention times and peak areas.	Evaluate %RSD for retention times (NMT 1%) and peak areas (NMT 15%).
	Detector Linearity: Plot concentration vs. peak responses.	Ensure detector response linearity (r2 > 0.99).
	Detector Noise and Drift: Monitor noise and drift over 15 minutes.	Measure noise (NMT 100 µV) and drift (NMT 2500 µV/hr).
HPTLC	Linearity of Spotting: Apply 2µl, 4µl, 6µl, 8µl, 10µl of solution, run in mobile phase, dry, scan, and check linearity.	Assess correlation coefficient between spots after applying various solution volumes (r^2 ≥ 0.99).
	Reproducibility of Spotting: Apply 10µl solution six times, run in mobile phase, dry, scan, and calculate %RSD (NMT 3.0%).	assess the system's plate-to-plate reproducibility, migration distance accuracy, and spot size precision.
	Detection Capacity: Spot stock solutions and observe at 254nm and 366nm to ensure visibility.	Validates the detection system's linearity, sensitivity, and wavelength accuracy.

Considerations for a Successful IQ, OQ and PQ:

Ensuring successful IQ involves meticulous planning, precise execution, and comprehensive documentation⁵². Pre-installation involves assessing location and space, documenting instruments, and gathering manuals. During installation, it's crucial to check instruments, ensure proper power, install ancillary equipment, and document details. Maintaining environmental conditions is key. Verification of software, connections, and documentation of calibration and validation^53-55 are vital. IQ Protocol outlines equipment details and requirements; IQ Checklist and Report cover installation, calibration, and environmental checks. Best practices include risk management integration^56-58, historical data use, clear criteria specification, document cross-referencing, nonconformity handling, flexibility planning, and visual aid use. Environmental factors⁵⁹ and training⁶⁰ ensure compliance and quality. Successful OQ hinges on meticulous scrutiny and adherence to predefined criteria that ensure equipment components impacting product quality operate within specified limits. These encompass a range of critical elements such as temperature control, servo motors, access systems, and environmental sensors. Key indicators of successful OQ include meeting acceptance criteria without significant deviations, effective error detection, seamless integration with other systems, positive user feedback, and thorough documentation in the OQ Protocol, Test Scripts/Checklists, Report, and Standard Operating Procedures (SOPs). Best practices involve testing equipment across its operational range, simulating failure modes, ensuring interoperability, evaluating performance under diverse environmental conditions, verifying data integrity, conducting sequential and load testing, and involving multidisciplinary teams in test planning and review processes to enhance protocol robustness and applicability.

PQ ensures the verification and documentation of user requirements, including normal operating ranges, essential for process validation^61-67. Unlike earlier phases, PQ evaluates integrated processes rather than individual components, enhancing overall system reliability. A robust test plan, ideally supplemented by third-party expertise, ensures comprehensive evaluation and adherence to quality standards. Process Performance Qualification (PPQ) protocols play a critical role in ongoing quality assurance by monitoring process performance over time. FDA guidelines mandate adherence to cGMP-compliant procedures, outlining criteria such as manufacturing conditions, comprehensive data recording, effective sampling plans, rigorous analysis methodologies, variability management, and contingency planning for non-conformances. Best practices encompass utilizing real-time monitoring tools, implementing Process Analytical Technology (PAT) for dynamic adjustments^68-72, and designing scalable protocols to anticipate production expansions and increased demands.

Applications of Analytical Instruments:

Analytical instruments are essential in various scientific fields for qualitative and quantitative analysis. i.e., they are suitable not only for identification and quantitation but also for establishing the composition and structure of materials. They play a vital role in pharmaceutical chemistry for quality control of various kinds of substances that ensure the safety, efficacy, and compliance of pharmaceutical products. The key applications of pH meter, electronic balance, UV visible spectrophotometer, FTIR, HPLC, GC and HPTLC were described in the Table 5^73-94.

Table 5: Applications of Analytical Instruments in Pharmaceutical Chemistry

S. No.	Instrument	Key Applications	Ref
1.	pH Meter	Determination of pH of APIs, formulations, Buffer solutions	[73]
2.	Electronic Balance	Accurate weighing of APIs and excipients Preparation of samples for quantitative analysis	[74]
3.	UV-Visible Spectrophotometer	Determination of λmax for APIs Quantification of drug substances in their formulations Estimation of drug release during dissolution studies	[75-78]
4.	FTIR Spectrophotometer	Identification of functional groups Verification of polymorphism in drugs Excipient compatibility studies	[79-82]
5.	HPLC	Assay of APIs and impurities, Stability studies (degradation product analysis) Chiral separation	[83-87]
6.	GC	Analysis of residual solvents, Volatile organic compounds and Purity profiling	[88,89]
7.	HPTLC	Fingerprint analysis of herbal drugs, Identification and quantification of active ingredients	[90-94]

CONCLUSION:

Ensuring the accuracy and reliability of analytical instruments is fundamental to the integrity of drug testing and quality assurance processes in the pharmaceutical industry. This comprehensive review underscores the importance of systematic qualification processes, which include DQ, IQ, OQ, and PQ, for maintaining the functionality, accuracy, and reliability of these instruments. Class II and III instruments, which are critical for accurate and reliable measurements, necessitate rigorous calibration and qualification to prevent any compromise in drug safety and efficacy. Detailed qualification protocols for widely used instruments such as electronic balances, pH meters, UV-Visible spectrophotometers, FTIR spectrometers, HPLC, GC, and HPTLC systems are outlined, highlighting the specific tests and criteria for each stage of qualification. These protocols ensure that instruments not only meet regulatory standards but also consistently perform within specified parameters, thereby supporting the production of safe and effective medicines. This review also provides practical considerations for successful IQ, OQ, and PQ, emphasizing the importance of meticulous planning, comprehensive documentation, and adherence to predefined criteria. These practices are crucial for verifying that equipment components impacting product quality operate within specified limits and for ensuring overall system reliability. As the industry continues to advance, the qualification processes must evolve to address new challenges and opportunities, ensuring the continued safety and efficacy of drug products. This review serves as a valuable resource for understanding and implementing effective qualification protocols, ultimately contributing to improved patient outcomes.

ACKNOWLEDGMENTS:

The authors would like to thank all contributors and reviewers whose invaluable insights and expertise greatly enhanced the quality of this manuscript.

CONFLICT OF INTEREST:

The authors declare that they have no competing financial interests.

REFERENCES:

1. Masoom RS, Zeid AA, Nafisur R. Analytical techniques in pharmaceutical analysis: A review. Arab. J. Chem. 2017 Feb; 10(1): S1409-21.doi: https://doi.org/10.1016/j.arabjc.2013.04.016

2. Velagaleti R, Burns PK and Gill M. Analytical Support for Drug Manufacturing in the United States’From Active Pharmaceutical Ingredient Synthesis to Drug Product Shelf Life. Ther Innov Regul Sci. 2003 Sept; 37: 407–438 (2003). doi: https://doi.org/10.1177/009286150303700407

3. Pezzola A, Sweet CM. Global pharmaceutical regulation: the challenge of integration for developing states. Global Health. 2016 Dec; 12(1):85. doi: 10.1186/s12992-016-0208-2.

4. Darshan Sonawane, Rutika Waghchaure, Rushikesh Aher, Khemchand Surana. Effective Application of the Quality Management System in the Pharmaceutical Industry. Asian Journal of Pharmaceutical Analysis. 2025; 15(2):146-2. doi: 10.52711/2231-5675.2025.00023

5. Elhassa GO, Alfarouk KO. Drug Development: Stages of Drug Development. J Pharmacovigilance. 2015 Jan; 03(03); e141. doi: 10.4172/2329-6887.1000e141.

6. Manirul Haque SK, Ratemi ES. Drug development and analysis review. Pharm. Chem. J. 2017 March; 50(12): 775-788. doi: 10.1007/s11094-017-1543-1

7. Ganesh UC, Vitthal. RG. The Stages of Drug Discovery and Development Process.  Int. J. of Pharm. Sci. 2024; 2(3): 474-82. doi: 10.5281/zenodo.10816178

8. Nidhi BA, Manoj K. Pharmaceutical Regulations in India. Pharmaceutical Medicine and Translational Clinical Research. Academic Press. 2018; 215-231. doi: https://doi.org/10.1016/B978-0-12-802103-3.00013-4

9. U.S. Food and Drug Administration (FDA). A Basic Guide to IQ, OQ, PQ in FDA-Regulated Industries. 2024. Available on https://www.thefdagroup.com/blog/a-basic-guide-to-iq-oq-pq-in-fda-regulated-industries

10. Jay M Jetani, Girish Pai K. A Comparative Review of the USFDA Guidelines on Process Validation Focusing on the Importance of Quality by Design (QbD). Research J. Pharm. and Tech. 2017; 10(4): 1257-1260. 10.5958/0974-360X.2017.00223.2

11. European Medicines Agency (EMA). EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Amsterdam: EMA, 2015, 4. Available on https://health.ec.europa.eu/document/download/7c6c5b3c-4902-46ea-b7ab-7608682fb68d_en?filename=2015-10_annex15.pdf

12. Surendra KB, Thomas L, Ernest DB, Marta H, Edward AH. Qualification of Analytical Instruments for Use in the Pharmaceutical Industry: A Scientific Approach. AAPS PharmSciTech. 2004 Apr; 5(1):E22. doi: 10.1208/pt050122

13. Gowrisankar D, Abbulu K, Bala Souri O, Sujana K. Validation and Calibration of Analytical Instruments. J. Biomed. Sci. Res., 2010; 2(2): 89-99.

14. Aparna CH, Gowrisankar D. A review on calibration of analytical instruments. Int. J. Pharm. Chem. Biol. Sci., 2015; 5(3): 572-582.

15. Devesh K, Ruchi BV, Diwaker D. An overview of analytical instrument qualification with reference of pharmaceutical industry. J. Drug Deliv. Ther. 2018; 8(5): 99-103.

16. Vinod DU, Rohit DU, Pooja PD, Vijay RC. A review: qualification of analytical instrument (Diffrential Scanning Colorimetry and Gas Chromatography). J Univ. Shanghai Sci. Tech. Aug 2022; 24(8): 93-118.

17. U.S. Pharmacopeia National Formulary: USP 39 NF 34. <1058> analytical instrument qualification. The United States Pharmacopeial Convention. Rockville, MD. 2016; 1055-1061.

18. Albert K, Krucker M, Glaser T, Schefer A, Lienau A, Zeeb D. Hyphenated techniques, Anal Bioanal Chem. 2002; 372(1): 25–26. doi: 10.1007/s00216-001-1158-x.

19. Vrijens B, Pironet A, Tousset E. The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results, Pharm Med. 2024; 38(1): 9–18. doi: 10.1007/s40290-023-00503-w.

20. Rachel JT, Christine CP, Obert PJ, Herbert PJ, Daniel W, Paul BW, et al. Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables, Front Pharmacol. 2020;11: 420. doi: 10.3389/fphar.2020.00420

21. Joakim R, Asa E. Mass Calibration Options for Accurate Electrospray Ionization Mass Spectrometry, Int. J. Mass Spectrom. 2021; 467: 116619. doi:  10.1016/j.ijms.2021.116619

22. McDowall RD. Instrument Qualification, Computerized System Validation and Method Validation. Validation in Thermal Analysis. Hanser. 2022; 26-36.

23. Dave VG. Instrument qualification and software validation. Separation Science and Technology. Academic Press. 2007, 8, 269-296.

24. Diksha J, Kaur H, Patil RK, Patil HC. Validation – In pharmaceutical industry: Equipment validation: A brief review, Adesh Univ. J. Med. Sci. Res. 2020; 2(2): 94-98. doi:10.25259/AUJMSR_15_2020

25. Kiranbala J, Meenakshi B. Qualification of equipments: a systematic approach Int. J. Pharm. Eru. May 2018; 08(1): 7-14.

26. Sharanya N, Ramasubramaniyan P, Jeya shree P, Srinag T, Palanichamy S, Solairaj P.  An overview on qualification of equipment - an ideal approach for equipment validation, Indo Am. J pharm. Res. Nov 2013, 3, 9013-9018.

27. Anubhav C, Vipin K. Equipment Qualification: A Systematic Method, Int. J. Pharm. Sci.  2024; 2(9): 1618-1623. doi: 10.5281/zenodo.13863449

28. Venugopal S.  A Systematic approach to Equipment Qualification, Eur. J. Biomed. Pharm. Sci. 2015; 2, 830-854.

29. Bedson P, Sargent M. The development and application of guidance on equipment qualification of analytical instruments, J Accredit. Qual. Assur. 1996; 1: 265-274. doi:10.1007/S007690050083

30. Likhitha B, Bhuvana C, Swathika B, Aroon, A.  Equipment qualification and maintenance in pharmaceutical manufacturing: strategies for efficiency and compliance. World J. Pharm. Res. 2024; 13(11): 298-306.

31. Bahubali N. Patil, Vamshi Krishna Tippavajhala, Girish Pai K. Equipment Qualification of a New Laboratory Tray Dryer. Research J. Pharm. and Tech. 2019; 12(2):805-811. 10.5958/0974-360X.2019.00140.9

32. U.S. Pharmacopeia National Formulary General Chapter <41> Balances. The United States Pharmacopeial Convention. Rockville, MD. 2014; 1055-1061.

33. Vinny C, Priya G. Review: Digital pH meter, Int. J. Creat. Res. Thoughts. Dec 2023; 11(12): 861-864.

34. Gurdeep RC, Sham KA. Instrumental Methods of Chemicals Analysis. Himalaya Publishing House. 2011.

35. Elsa M, Andiny FHS, Jedidya RS, Triaugust AM, Raudiya MD, Andi DP. UV-Vis spectrophotometry for rapid and specific quantification of amphotericin B: analytical method validation for ex vivo and in vivo studies in the development of nanoemulsion-incorporated thermosensitive gel. Anal Sci. Apr 2024; 40(4): 615-631. doi: 10.1007/s44211-023-00493-4.

36. Kiran J, Dinesh D, Amol T, Harshad T, Mrityunjaya P. Application of UV spectrophotometric method for easy and rapid estimation of lafutidine in bulk and pharmaceutical formulation Pharm. Methods. Oct 2011; 2(4): 117-120. doi: 10.4103/2229-4708.93398

37. Bikash RJ, Suryakanta S, Debashish G, Rajib LM, Sravani D. New UV spectrophotometric Method for the estimation of Lumefantrine in pharmaceutical formulations, Int. J. Recent Sci. Res. Feb 2021; 12(2): 40955-40960. doi:: http://dx.doi.org/10.24327/ijrsr.2021.1202.5799

38. David G. Watson. Pharmaceutical analysis: A Text Book for Pharmacy Students and Pharmaceutical Chemists. Churchill Livingstone, Elsevier, 2020.

39. Matthew E, Michael P, Chayanee C, Mohammed J, Steve S, David J. Establishment of instrument operation qualification and routine performance qualification procedures for handheld near-infrared spectrometers used at different locations within a laboratory network, Spectrochim. Acta A Mol. Biomol. Spectrosc. Feb 2022, 267(1): 120512. Doi: https://doi.org/10.1016/j.saa.2021.120512

40. Ali AH. Ann. High-Performance Liquid Chromatography (HPLC): A review, Adv. Chem. June 2022; 6(1): 010-020. doi: 10.29328/journal.aac.1001026

41. Lukas K, Matthias D, Joachim E, Claus F, Heidemarie H, Peter L. Efficient and economic HPLC performance qualification, J. Pharm. Biomed. Anal. Sept 2009; 51(3): 557-64. doi: 10.1016/j.jpba.2009.09.011

42. Rameshwar G, Sanjay P, Sailesh W, Tukaram K. Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form, Futur J Pharm Sci. Nov 2021; 7:224. doi: https://doi.org/10.1186/s43094-021-00369-2

43. Venkateswara Rao A, Sai Kumar B, Harish J, Bhagya Kumar T, Eswarlal T. Characterization of Forced Degradation Products of Netarsudil: Optimization and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Quantification of Process-Related Impurities, Turk J Pharm Sci. June 2024; 21(3): 224-233. doi: 10.4274/tjps.galenos.2023.99148

44. Vidya S, Manasi J, Prafulla S. Bioanalytical method development, validation and quantification of flutamide in spiked rat plasma by using high-performance liquid chromatography, Futur J Pharm Sci. Aug 2023, 9:75. doi: https://doi.org/10.1186/s43094-023-00528-7

45. United States Pharmacopoeia. 27^th ed. 2004. The USP Convention Inc., Rockville, MD.

46. European Pharmacopoeia, 4^th ed., 2002, 55.

47. Harshal DP, Chandrabhan BP, Vikas VP, Pankaj SP, Amol RP. A Brief Review on Gas Chromatography. Asian J. Pharm. Anal. 2023; 13 (1): 47-52.

48. Fayed AS, Shehata MA, Hassan NY, El Weshahy SAJ. Validated HPLC and HPTLC Stability-Indicating Methods for Determination of Alfuzosin Hydrochloride in Bulk Powder and Pharmaceutical Formulations, Sep. Sci. 2006; 29(18): 2716-2724. doi:10.1002/jssc.200600220

49. Zainab AJE, Dan B, Daniela LB, Claudia MG, Mihaela I. HPTLC method for the assay of tramadol and pentazocine from mixtures, Farmacia. 2011, 59 (3): 381-387.

50. Neumann C, Margot P. New perspectives in the use of ink evidence in forensic science: Part I. Development of a quality assurance process for forensic ink analysis by HPTLC. Forensic Sci Int., Mar 2009; 185(1-3): 29-37. doi: 10.1016/j.forsciint.2008.11.016.

51. Beat M, Daniela S. Modern HPTLC-A perfect tool for quality control of herbals and their preparations, J. AOAC Int. Sept 2010;93(5):1399-409. doi:  10.1093/jaoac/93.5.1399

52. Nikita Sawant, Bharati P. Caudhari, V. K. Redasani, Saniya Mulla. Documentation in Pharmaceutical Industry. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3): 315-1. doi: 10.52711/2231-5659.2025.00046

53. Sharma P.P. Validation in Pharmaceutical Industry (6th ed). United Kingdom: Informa Healthcare Publication. 2016.

54. Nandhakumar L, Dharmamoorthy G, Rameshkumar S, Chandrasekaran S. An overview of pharmaceutical validation: qualityassurance view point. Int J Res Pharm Chem. 2011; 1: 1003-1014.

55. Todde S, Kolenc Peitl P, Elsinga P, Koziorowski J, Ferrari V, Ocak EM. Guidance on validation and qualification of processes and operations involving radiopharmaceuticals. EJNMMI Radiopharm Chem. 2017; 2(8). doi: 10.1186/s41181-017-0025-9

56. Evdoxia T, Argyro GF, Agapios ΝP. Identifying risk management challenges in laboratories, Accreditation and Quality Assurance. 2023; 28(4): 167–179. doi:  10.1007/s00769-023-01540-3

57. Covello VT, Mumpower J. Risk Analysis and Risk Management: An Historical Perspective. Risk Anal. 1985; 5(2): 103–120. doi: 10.1111/j.1539-6924.1985.tb00159.x

58. Dionne G. Risk Management: History, Definition, and Critique. Risk Manag Insur Rev. 2013; 16(2): 147–166. doi: https://doi.org/10.1111/rmir.12016

59. Lemos J, Gaspar PD, Lima TM. Environmental Risk Assessment and Management in Industry 4.0: A Review of Technologies and Trends, Machines. 2022; 10(8): 702. https://doi.org/10.3390/machines10080702.

60. Bates DW, Gawande AA. Improving safety with information technology, N Engl J Med. 2003 Jun 19; 348(25): 2526-34. doi: 10.1056/NEJMsa020847.

61. Alam SM. Pharmaceutical Process Validation: An Overview, J. Adv. Pharm. Educ. Res. Dec 2012; 2(4): 185-200.

62. Tenzin W, Rathore DS, Yogendra Singh. Pharmaceutical Process Validation: A Mini Review, Int. J. health Biol. Sci. 2019; 2(2):9-12.

63. Sharma A, Saini S. Process Validation of Solid Dosage Form: A Review. Int. J Res. in Pharm. Sci. 2013; 3(2): 12- 30.

64. Nash RA, Alfred HW. Pharmaceutical process validation. 3^rd ed, New York:

65. Marcel Dekker Inc. 2003, 41-46.

66. Keyur BA, Khushboo DS, Sushma PY, Hetal S Patel, Chetan BP. Overview of Validation and Basic Concepts of Process Validation, Sch. Acad. J. Pharm. 2014; 3(2):178-190.

67. Loftus BT. The Regulatory Basis for Process Validation. Pharmaceutical Process Validation. Marcel Dekker, New York, 1984.

68. Prajkta M. Ghagare, Ashwini R. Patil, Bhavna J. Deshmane, Manish S. Kondawar. Review on Pharmaceutical Validation. Res. J. Pharma. Dosage Forms and Tech. 2020; 12(1): 17-26. 10.5958/0975-4377.2020.00004.X

69. Jacques Wiss. Process Analytical Technology: tools and applications in pharmaceutical manufacturing, Chimica Oggi - Chemistry Today. 2015; 33(2): 30-33.

70. Punita Raj, N. Vishal Gupta. Process Analytical Technology (PAT): A Real Time Quality Assurance. Int. J. Pharm. Sci. Rev. Res. 2016; 37(2): 67-72.

71. Rakshit VT, Vidhi NK, Nishendu PN, Parula BP. A complete review of process analytical technology (PAT),  Int. J. Pharm. Sci. Rev. Res. 2012, 17(1): 57-65.

72. Eun Ji K, Ji Hyeon K, Min-Soo K, Seong Hoon, J, Du Hyung C. Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification, Pharmaceutics. 2021; 13(6): 919. doi: 10.3390/pharmaceutics13060919.

73. Dipti G. Phadtare, Pawar Amol R, R.B. Saudagar. A Brief Review on Quality by Design and Process Analytical Technology. Asian J. Pharm. Ana. 2016; 6(2): 122-130. doi: 10.5958/2231-5675.2016.00019.3

74. Silvia VB, Lara GF, María CDP, Carlos CD. pH determination as a quality standard for the elaboration of oral liquid compounding formula, Farmacia Hospitalaria. 2018; 42(6): 221-227. DOI: https://doi.org/10.7399/fh.10932

75. Klaus F. Metrology of weighing in the pharmaceutical industry. Measurement Sensors. 2021; 18(3):100262. DOI: 10.1016/j.measen.2021.100262

76. Rajendra Prasad A, Thireesha B. UV-spectrophotometric method development and validation for the determination of lornoxicam in microsponges. International Journal of Applied Pharmaceutics. 2018; 10(1):74, 2018. Doi: 10.22159/ijap.2018v10i1.22357

77. Mahfuza M, Raquibul HM, Farhad H, Sanjana S. Development and validation of a simple UV spectrophotometric method for the determination of levofloxacin both in bulk and marketed dosage formulations, J Pharma. Anal. 2012; 2(6): 2012; 454-457. DOI: https://doi.org/10.1016/j.jpha.2012.06.004

78. Benedict B, Adam W, Zayeem F, Jesper O, Kofi AA. Application of UV dissolution imaging to pharmaceutical systems, Adv. Drug Del. Rev. 2021; 177: 113949. DOI: https://doi.org/10.1016/j.addr.2021.113949

79. K. Soumya, S. Susanna, T.E.G.K. Murthy. In vitro Dissolution Studies on Commercial Brands Containing Immediate Release Pioglitazone and Metformin Hydrochloride Extended Release Tablets. Res. J. Pharm. Dosage Form. and Tech. 2017;  9(1): 15-18. doi: 10.5958/0975-4377.2017.00003.9

80. Kedir DM. Fourier transform infrared spectroscopy as a tool for identifying the unique characteristic bands of lipid in oilseed components: Confirmed via Ethiopian indigenous desert date fruit. Heliyon. 2023; 9(4): e14699. DOI: https://doi.org/10.1016/j.heliyon.2023.e14699

81. Fermin FHA, Clement MH, Paulo CM, Bruce V. Polymorphism characterization of segesterone acetate: A comprehensive study using XRPD, FT-IR and Raman spectroscopy. Int. J Pharm. 2021; 596: 120234. DOI: https://doi.org/10.1016/j.ijpharm.2021.120234

82. M Blanco, J Coello, H Iturriaga, S Maspoch, C Pérez-Maseda. Determination of polymorphic purity by near infrared spectrometry. Anal. Chimica Acta. 2000; 407(1–2): 247-254. DOI: https://doi.org/10.1016/S0003-2670(99)00828-4

83. Syrine FD, Alia DE, Ralph GF. Drug-Excipient Compatibility Testing of Cilostazol Using FTIR and DSC Analysis. Philippine J Sci. 2023; 152(6A): 2129-2137.

84. Derouicha M, Nadjib H, Khalil FEH, NHZ, Houari T. Analysis of Drug-Related Impurties by HPLC in Ciprofloxacin Hydrochloride Raw Material. Turk J Pharm Sci. 2022;19(3):293–304. DOI: 10.4274/tjps.galenos.2021.70594

85. Samuel A, Chithra M, June G, Mark R, Wayne S. Chiral HPLC analysis of formoterol stereoisomers and thermodynamic study of their interconversion in aqueous pharmaceutical formulations. J Pharma. Biomed. Ana. 2009; 49(3): 632-637, DOI: https://doi.org/10.1016/j.jpba.2008.12.004

86. Priti RD, Vinod LG, Preeti KT, Kakasaheb RM, Ravindra NP. Development of stability-indicating HPLC method and accelerated stability studies for osmotic and pulsatile tablet formulations of Clopidogrel Bisulfate. J Pharm. Biom. Ana. 2019; 165: 346-356. DOI: https://doi.org/10.1016/j.jpba.2018.12.020

87. Hamid Khan, Javed Ali. UHPLC: Applications in Pharmaceutical Analysis. Asian J. Pharm. Ana. 2017; 7(2): 124-131. doi: 10.5958/2231-5675.2017.00020.5

88. Debi Prasad Pradhan, Mukthinuthalapati Mathrusri Annapurna .Stability indicating HPLC-DAD method for the determination of Oxcarbazepine - An Anticonvulsant. Research J. Pharm. and Tech. 2019; 12(2):723-728. doi: 10.5958/0974-360X.2019.00128.8

89. Saurabh P, Preeti P, Raj Kumar, Narendra Pal S. Residual solvent determination by head space gas chromatography with flame ionization detector in omeprazole API. Braz. J Pharm. Sci. 2011; 47(2): 379-384.

90. Jo Dewulf, Herman Van Langenhove, Gyula Wittmann. Analysis of volatile organic compounds using gas chromatography, Trends in Ana. Chem. 2002; 21(9–10): 637-646. DOI: https://doi.org/10.1016/S0165-9936(02)00804-X

91. Amit Yadaorao Saraf, Aparna Amit Saraf. HPTLC Fingerprinting: A Tool for Simplified Analysis of Phenolics in Medicinal Plants, Ind. J Pharm. Edu. Res. 2020; 54(4): 1098-1103. DOI: 10.5530/ijper.54.4.205

92. Bhaskar O. Aher, Yogesh T. Sonawane, Vinod A. Bairagi, Parag A. Pathade. HPTLC Method for Estimation of Ellagic Acid and Gallic Acid from Flowers of Woodfordia fruticosa Kurz. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3):187-2. doi: 10.52711/2231-5659.2021.00029

93. Tripti Jain, Amber Vyas, Darshan Dubey, Kamlesh Dashora, Vishal Jain. Development of Fingerprinting Method for Estimation Glycyrrhizinic acid in Ayurvedic formulation Eladi Gutika: A HPTLC approach. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(4):277-0. doi: 10.52711/2231-5659.2022.00047

94. Chetan Salunke, Kailaspati Chittam, Amol Pawar, Harshal Chaudhari. Development of an Analytical Method to Determine Extracts of Different Species of Glycyrrhizin by HPTLC. Res. J. Pharma. Dosage Forms and Tech. 2020; 12(2): 89-92. doi: 10.5958/0975-4377.2020.00016.6

95. Aishwarya P. Joglekar. Method Development and Validation for the Estimation of Telmisartan and Chlorthalidone in Bulk and Pharmaceutical Dosage form by HPTLC Method. Research J. Pharm. and Tech. 2015; 8(4): 376-381. doi: 10.5958/0974-360X.2015.00063.3

Received on 04.08.2025      Revised on 28.11.2025

Accepted on 31.01.2026 Published on 06.07.2026

Available online from July 20, 2026

Asian J. Pharm. Res. 2026; 16(3):275-284.

DOI: 10.52711/2231-5691.2026.00041

©Asian Pharma Press All Right Reserved

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.